SC
RMD icon

Syon Capital’s ResMed RMD Stock Holding History

Syon Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Buy
5,311
+1,907
+56% +$395K 0.05% 343
2026
Q1 		$764K Buy
3,404
+161
+5% +$40.1K 0.04% 396
2025
Q4 		$781K Buy
3,243
+487
+18% +$125K 0.04% 389
2025
Q3 		$754K Buy
2,756
+815
+42% +$223K 0.04% 338
2025
Q2 		$501K Buy
1,941
+593
+44% +$141K 0.03% 375
2025
Q1 		$302K Buy
1,348
+158
+13% +$36.9K 0.02% 428
2024
Q4 		$272K Buy
+1,190
New +$287K 0.02% 430

Other funds holding RMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Syon Capital's RMD Position: Q2 2026 in Review

Syon Capital increased its ResMed (RMD) stake by 56% in Q2 2026, buying an estimated $395K and bringing the position to 5,311 shares worth $1.04M. The position accounts for 0.05% of the portfolio, ranked #343.

Syon Capital first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. 889 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • Syon Capital held 5,311 shares of ResMed worth $1.04M as of Q2 2026.
  • Syon Capital bought 1,907 ResMed shares in Q2 2026, an estimated $395K.
  • ResMed made up 0.05% of Syon Capital's portfolio in Q2 2026, its #343 holding.
  • Syon Capital first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
  • 889 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.